Publicaciones en las que colabora con Jesús F. San Miguel (9)

2015

  1. The cellular origin and malignant transformation of Waldenström macroglobulinemia

    Blood, Vol. 125, Núm. 15, pp. 2370-2380

2014

  1. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: New criteria for differential diagnosis and risk stratification

    Leukemia, Vol. 28, Núm. 1, pp. 166-173

2011

  1. The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis

    Blood, Vol. 117, Núm. 13, pp. 3613-3616

2008

  1. Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma

    British Journal of Haematology, Vol. 141, Núm. 2, pp. 212-215

2006

  1. Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain

    Leukemia Research, Vol. 30, Núm. 8, pp. 943-948

  2. The association of increased p14 ARF/p16 INK4a and p15 INK4b gene expression with proliferative activity and the clinical course of multiple myeloma

    Haematologica, Vol. 91, Núm. 11, pp. 1551-1554

2005

  1. Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 68-72

2002

  1. The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma

    Hematology Journal, Vol. 3, Núm. 1, pp. 43-48

2000

  1. Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation

    Bone Marrow Transplantation, Vol. 26, Núm. 11, pp. 1229-1230